AxoGen Inc reports results for the quarter ended in March - Earnings Summary

AxoGen

03/05/2024 10:51

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 6
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -10
cents.  The mean expectation of five analysts for the quarter
was for a loss of 7 cents per share. Wall Street expected
results to range from -16 cents to -2 cents per share.
    * Revenue rose 12.9% to $41.38 million from a year ago;
analysts
expected $41.96 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 15
cents​.
    * The company reported a quarterly loss of $6.64 million.
    * AxoGen Inc shares had fallen by 27.1% this quarter and
lost 13.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 192.5% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for AxoGen Inc is
$13.00 
This summary was machine generated from LSEG data May 3 at 09:50
a.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.07          -0.06          Beat
 Dec. 31 2023      -0.10          -0.06          Beat
 Sep. 30 2023      -0.06          0.01           Beat
 Jun. 30 2023      -0.13          -0.03          Beat